Role of Contrast Enhanced Digital Mammography in Female Patients With Pathological Nipple Discharge

NCT04651257 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-12-03

No results posted yet for this study

Summary

To evaluate the validity of contrast enhanced digital mammography in evaluation of pathological nipple discharge .

Conditions

  • Contrast Mammography in Pathological Nipple Discharge

Interventions

DEVICE

Contrast mammography (CEM)

Contrast mammography in pathological nipple discharge

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2022-09-30
Completion
2022-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04651257 on ClinicalTrials.gov